Baker, D., Bimali, M., Carrillo, L., Sachedina, A., Alapat, D., Hoque, M. S., … Schinke, C. (2021). Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status. Haematologica, 106(12), 3215–3218. https://doi.org/10.3324/haematol.2021.278779

Baker, David, Milan Bimali, Luis Carrillo, Archana Sachedina, Daisy Alapat, Md Shadiqul Hoque, Mathew Kottarathara, et al. “Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status.” Haematologica 106, no. 12 (December 1, 2021): 3215–18. https://doi.org/10.3324/haematol.2021.278779.

Baker D, Bimali M, Carrillo L, Sachedina A, Alapat D, Hoque MS, et al. Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status. Haematologica. 2021 Dec 1;106(12):3215–8.

Baker, David, et al. “Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status.” Haematologica, vol. 106, no. 12, Dec. 2021, pp. 3215–18. Pubmed, doi:10.3324/haematol.2021.278779.

Baker D, Bimali M, Carrillo L, Sachedina A, Alapat D, Hoque MS, Kottarathara M, Parikh R, Erra A, Mitma AA, Mathur P, Ogunsesan Y, Yarlagadda L, Gundarlapalli S, Thanendrarajan S, Zangari M, Van Rhee F, Tricot G, Schinke C. Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status. Haematologica. 2021 Dec 1;106(12):3215–3218.